[Drug therapy of Parkinson's disease].
作者信息
Myllylä V
机构信息
Oulun yliopiston lääketieteellinen tiedekunta.
出版信息
Duodecim. 1997;113(18):1827-34.
PMID:10892076
Abstract
摘要
相似文献
1
[Drug therapy of Parkinson's disease].[帕金森病的药物治疗]
Duodecim. 1997;113(18):1827-34.
2
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.帕金森病治疗的最新进展：单胺氧化酶抑制剂的应用
Expert Rev Neurother. 2005 Nov;5(6):811-21. doi: 10.1586/14737175.5.6.811.
3
[Optimization of the treatment of Parkinson's disease using dopamine agonists].[使用多巴胺激动剂优化帕金森病治疗]
Arch Neurobiol (Madr). 1991 Nov-Dec;54(6):282-7.
4
Future therapies for Parkinson's disease.帕金森病的未来疗法。
Neurol Clin. 2004 Oct;22(3 Suppl):S149-66. doi: 10.1016/j.ncl.2004.05.005.
5
DATATOP-study: significance of its results in the treatment of Parkinson's disease.DATATOP研究：其结果在帕金森病治疗中的意义
J Neural Transm Suppl. 1995;46:391-7.
6
Moderate Parkinson's disease. Strategies for maximizing treatment.中度帕金森病。优化治疗的策略。
Postgrad Med. 1996 Jan;99(1):52-4, 61-3, 67-8, passim.
7
Selegiline in Parkinson's disease.司来吉兰治疗帕金森病
BMJ. 1995 Dec 16;311(7020):1583-4. doi: 10.1136/bmj.311.7020.1583.
8
Treatment of Parkinson's disease.帕金森病的治疗。
Aust Fam Physician. 1995 Sep;24(9):1685-7, 1690-2.
9
Treatment options for early Parkinson's disease.早期帕金森病的治疗选择。
Am Fam Physician. 1996 Mar;53(4):1281-7.
10
Deprenyl and levodopa and Parkinson's disease progression.司来吉兰、左旋多巴与帕金森病进展
Ann Neurol. 1996 Aug;40(2):267-8. doi: 10.1002/ana.410400228.
Zotero 插件